Veru

VERU

ATLANTA, GA – – (ACCESSWIRE – December 7, 2022) – – Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU).  The lawsuit alleges Veru made materially false and misleading statements and/or failed to disclose material adverse facts about data from a Phase 3 clinical trail for the Company’s drug, sabizabulin, and about Veru’s interactions with the FDA. Specifically, Veru mislead shareholders to believe its Phase 3 data was sufficient to support an Emergency Use Authorization (“EUA”) and even a New Drug Application (“NDA”) without further studies.

If you bought shares of Veru between May 11, 2022 and November 9, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at https://holzerlaw.com/case/veru/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is February 6, 2023.

Registration Deadline

Lead Plaintiff Deadline Has Passed

February 6, 2023

Submit Your Information

Name(Required)
Address
MM slash DD slash YYYY
Shares Purchased(Required)
Number of Shares Acquired
Acquisition Price Per Share
 
MM slash DD slash YYYY
Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.